“BMI and TLC Influences Doxorubicin Epirubicin Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer”. Majalah Kedokteran Bandung 54, no. 4 (December 31, 2022): 221–227. Accessed July 6, 2026. https://beta.unpadmedjournals.id/index.php/mkb/article/view/2797.